Emiko Waight
Overview
Explore the profile of Emiko Waight including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang C, Su H, Waight E, Poluektova L, Gorantla S, Gendelman H, et al.
Pharmaceuticals (Basel)
. 2024 Feb;
17(2).
PMID: 38399364
Disordered immunity, aging, human immunodeficiency virus type one (HIV-1) infection, and responses to antiretroviral therapy are linked. However, how each factor is linked with the other(s) remains incompletely understood. It...
2.
Dash P, Chen C, Kaminski R, Su H, Mancuso P, Sillman B, et al.
Proc Natl Acad Sci U S A
. 2023 May;
120(19):e2217887120.
PMID: 37126704
Treatment of HIV-1-infected CD34+ NSG-humanized mice with long-acting ester prodrugs of cabotegravir, lamivudine, and abacavir in combination with native rilpivirine was followed by dual CRISPR-Cas9 C-C chemokine receptor type five...
3.
Shahjin F, Patel M, Machhi J, Cohen J, Nayan M, Yeapuri P, et al.
Acta Biomater
. 2022 Dec;
158:493-509.
PMID: 36581007
Effective antigen delivery facilitates antiviral vaccine success defined by effective immune protective responses against viral exposures. To improve severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antigen delivery, a controlled biodegradable, stable,...
4.
Waight E, Zhang C, Mathews S, Kevadiya B, Lloyd K, Gendelman H, et al.
J Leukoc Biol
. 2022 Aug;
112(5):1285-1295.
PMID: 36044375
The HIV-1 often evades a robust antiretroviral-mediated immune response, leading to persistent infection within anatomically privileged sites including the CNS. Continuous low-level infection occurs in the presence of effective antiretroviral...
5.
Su H, Sravanam S, Sillman B, Waight E, Makarov E, Mathews S, et al.
J Neuroimmune Pharmacol
. 2021 Sep;
16(4):796-805.
PMID: 34528173
Defining the latent human immunodeficiency virus type 1 (HIV-1) burden in the human brain during progressive infection is limited by sample access. Human hematopoietic stem cells (hu-HSCs)-reconstituted humanized mice provide...
6.
Dash P, Gorantla S, Poluektova L, Hasan M, Waight E, Zhang C, et al.
Retrovirology
. 2021 Jun;
18(1):13.
PMID: 34090462
Humanized mice model human disease and as such are used commonly for research studies of infectious, degenerative and cancer disorders. Recent models also reflect hematopoiesis, natural immunity, neurobiology, and molecular...